Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ularitide for acute decompensated heart failure
ACTRN12605000707662Phase 2Not yet recruiting
- Sponsor
- PDL BioPharma
- Start
- Jan 2006
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in heart failure (HF) comparing Ularitide + standard therapy with Placebo + standard therapy (2 arms). Primary endpoints: Safety comparison of ularitide versus placebo and Efficacy comparison of ularitide versus placebo. Planned start Jan 2006; status: not yet recruiting.
02
Drugs
ularitide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ACTRN12605000707662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000707662.